Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 323.93M | 320.35M | 322.67M | 315.55M | 303.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 323.93M | 320.35M | 322.67M | 315.55M | 303.22M |
| Cost of Revenue | 208.67M | 196.33M | 191.80M | 185.41M | 181.82M |
| Gross Profit | 115.26M | 124.02M | 130.88M | 130.14M | 121.40M |
| SG&A Expenses | 165.11M | 161.66M | 158.11M | 141.29M | 136.39M |
| Depreciation & Amortization | 8.69M | 8.07M | 8.03M | 8.00M | 7.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 439.22M | 421.75M | 411.84M | 386.54M | 375.95M |
| Operating Income | -115.29M | -101.40M | -89.17M | -70.99M | -72.72M |
| Income Before Tax | -92.45M | -84.28M | -70.03M | -48.80M | -59.82M |
| Income Tax Expenses | -6.98M | -9.27M | -8.39M | -4.63M | -7.78M |
| Earnings from Continuing Operations | -85.47 | -75.01 | -61.63 | -44.17 | -52.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.09M | 1.20M | 1.12M | 1.19M | 1.02M |
| Net Income | -84.38M | -73.81M | -60.51M | -42.98M | -51.02M |
| EBIT | -115.29M | -101.40M | -89.17M | -70.99M | -72.72M |
| EBITDA | -89.46M | -77.20M | -65.05M | -46.79M | -48.64M |
| EPS Basic | -2.83 | -2.40 | -1.97 | -1.40 | -1.67 |
| Normalized Basic EPS | -1.75 | -1.38 | -1.14 | -0.75 | -0.78 |
| EPS Diluted | -2.83 | -2.40 | -1.97 | -1.40 | -1.67 |
| Normalized Diluted EPS | -1.75 | -1.38 | -1.14 | -0.75 | -0.78 |
| Average Basic Shares Outstanding | 120.62M | 123.16M | 123.11M | 122.78M | 122.44M |
| Average Diluted Shares Outstanding | 120.62M | 123.16M | 123.11M | 122.78M | 122.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |